Faze Medicines
About:
Faze Medicines is a biotechnology company.
Website: https://www.fazemed.com
Twitter/X: fazemedicines
Top Investors: Eli Lilly, Alexandria Venture Investments, AbbVie, Invus, Catalio Capital Management
Description:
Faze Medicines is a biotechnology company that uses a variety of screening and proteomics techniques to define condensate interaction networks.
Total Funding Amount:
$81M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2020-01-01
Contact Email:
info(AT)fazemed.com
Founders:
J. Paul Taylor, Mike Rosen, Ron Vale, Roy Parker
Number of Employees:
11-50
Last Funding Date:
2020-12-10
IPO Status:
Private
Industries:
© 2025 bioDAO.ai